What is the most likely diagnosis for this patient?
Frits van Rhee, MD, PhD, University of Arkansas for Medical Sciences, says the first point to make is that a false positive screen for autoimmune disease occurs in about 30% of patients. If one finds that this test is positive, it is necessary to do more sophisticated blood testing, and this was completed in this patient. Very specific tests for lupus were conducted, and they were negative, so lupus was ruled out. Lymphoma was ruled out as well. A stain on the lymph node ruled out Epstein-Barr Virus infection, and then the patient was found to have generalized lymphadenopathy. In that constellation, one needs to seriously consider that the correct diagnosis is multicentric Castleman’s disease.
Guess the Diagnosis: Case 2
Mark F. is a 25-year-old law school student from Florida with a 3-week history of severe fatigue, night sweats, and weight loss; he has also reported high fevers for the past week. He did not complain of joint pain.
The patient was admitted for further assessment.
Mark’s SLE diagnosis was reviewed and further testing was performed:
Examining the Non-Hodgkin Lymphoma Treatment Paradigm
July 15th 2022In season 3, episode 6 of Targeted Talks, Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.
Listen
Superior Outcomes With Brentuximab Vedotin Triplet in Diffuse Large B-Cell Lymphoma
September 11th 2024The addition of brentuximab vedotin to lenalidomide and rituximab significantly improved survival and response vs lenalidomide/rituximab alone in patients with relapsed/refractory DLBCL.
Read More